A Growing Problem

One in Five Americans will get Skin Cancer in their Lifetime

Skin Cancer a growing problem among the aging population

Skin cancer accounts for more than 40% of all malignancies in the United States. Moreover, greater than 50% of skin cancers occur in those over 60 years of age. This population also has a high incidence of risk associated with surgical procedures due to various disorders like diabetes and cardiac diseases that can slow the healing process.

The traditional treatment path for non-melanoma skin cancer has been Mohs surgery. This surgery involves a series of excisions of cancerous tissue and surrounding healthy tissue until the cancer can no longer be detected. This procedure can lead to substantial cosmetic surgery requirements and a drawn-out healing process which can result in infection.

Therapy Modalities Comparison

XStrahl-100™  VS
srt strip1

Mohs Surgery

Y
Y
N
1-3 hours
Surgery
Incision
Invasive
0-2 cm
N
Y
Y
Recon. Surgery
High
$1,270
1
30 to 50
Surgery/Staff/Lab
N
Y
Dermatologist Only
98%
2%
srt strip2

LINAC EBRT

Y
Y
Y
30 Min
High Dose Radiation
Electrons
Invasive Beam
1-50 cm
20-35 Fractions
N
N
N
Very High
$4,700
2
15 to 25
Concrete Vault
N
N
RadOnc Only
88%
12%
srt strip3

Brachytherapy

Y
Y
N
30 Min to 1 hour
High Energy Isotopes
Gamma Particles
Superficial/Interstitial
0-1 cm
6-15 Fractions
Y
When Interstitial
N
High
$5,250
2
5 to 10
Heavy Shielding
Y
Y
RadOnc Only
95%
5%
srt strip4

Photodynamic

Y
Y
N
30 Min
High Energy Light
Photons
Superficial
4 mm
N
Y
N
N
Low
N/A
2
N/A
Photosensitive Drugs
Y
Y
Dermatologist
70%
30%
srt strip5

Topicals

Y
Y
N
10 Min
Chemotherapy
Bio-Chemical
Superficial
0 cm
40-200 Fractions
N
N
N
Low
N/A
6
N/A
None
Y
Y
Dermatologist
65%
35%
.

Parameters

SRT

Basal Cell Y
Squamous Cell Y
 Melanoma N
 Procedure Time 90 sec
 Treatment Type Low Dose X-ray
Particle Type/Delivery Mode Photons
 Modality Therapy Mode Superficial
Penetration Rate 0-1 cm
 Fractionated Treatment 5-22 Fractions
 Pain Involved? N
 Anesthesia Required? N
 Post-Procedural Treatment N
 Practice Setup/Cost of Entry Low
 Avg. Reimbursement / Patient $1,350
 Max. Patient Throughput / Hr 12
 Break-even Patients / Month 3 to 4
 Special Provisions Minimal Shielding
 Mobile? Y
Ongoing Consumable Costs? N
Who Can Administer Dermatologist/RadOnc
Cure Rates 98%
Recurrence Rates 2%

 Source:  ©2011

srt safety other other other other other other

According to the National Cancer Institute, the estimated total direct cost associated with the treatment of melanoma in 2010 was $2.36 billion.

Source: "The Cost of Cancer." National Cancer Institute at the National Institutes of Health. 2011.  http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/costofcancer. (last accessed 26 Aug. 2011).